Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Patient Compliance × Acupuncture Points × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Vomiting 1 Rectal Neoplasms 1 Patient Compliance 1 Nausea 1 Liver Neoplasms 1 Breast Neoplasms 1

Interventions

Patient Navigation 2 Interviews as Topic 2 Exercise 2 regorafenib 1 potassium oxonate 1 beta-Aminoethyl Isothiourea 1 Weights and Measures 1 Videotape Recording 1 Trastuzumab 1 Surveys and Questionnaires 1 Standard of Care 1 Radiation 1 Psychosocial Intervention 1 Oxaliplatin 1 Ocoxin 1 N-(3-chloro-4-((3-fluorobenzyl)oxy)phenyl-6-(5-((methylsulfonyl)ethyl)aminomethyl)-2-furyl)-4-quinazolinamine 1 Metabolism 1 Leuprolide 1 Lapatinib 1 Goserelin 1 Diet 1 Cisplatin 1 Capecitabine 1 Acupuncture Points 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04749381 2021-02-11

RCT

Peking University Cancer Hospital & Institute

Phase 2 Unknown

Gastrointestinal

Patient Compliance, Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡